Please find below recent news about events and vacancies in our area, as well as links to some other resources related to the cheminformatics field and beyond.
In particular I would like to alert everyone to our next ‘In Silico Toxicology’ Network Meeting on 30 September 2020 – this time we will hold the event via Zoom (free and open to all), registration just opened. Please join us! See http://drugdiscovery.net/tox2020/ for details.
(see also previous newsletter for some events still current:
12 June – 17 September 2020
Milner Therapeutics Symposium (online, free)
26 June 2020
Putting AI into Practice (online, free)
2 September 2020
Cambridge Cheminformatics Meeting (online, free)
We are looking for speakers for the next events, which will be both virtual and (when possible again) physically. Please let me know if you wish to present either way!
Next dates: http://www.c-inf.net
Registration open, programme TBC
21-25 September 2020
OpenTox 2020 Virtual Conference (online)
30 September 2020
In Silico Toxicology Network Meeting (online, free)
12 October 2020 – 10 March 2021
Pistoia Alliance Second Drug Repurposing Datathon (online, free)
Scientific Data Curator PDB/EMDB
Data Scientist, Structural Bioinformatics
Director of Drug Discovery
Post Doctoral Scientist (m/w/d) Data Science/Artificial Intelligence in Drug Discovery
Cheminformatics Data Science Group Leader
Validating the validation: reanalyzing a large-scale comparison of deep learning and machine learning models for bioactivity prediction
So … did we crack the nut of drug discovery with deep learning and ‘AI’, or not yet? (Or don’t we know yet… or can’t we even say yet whether we know already, or not)?
Chemists: AI Is Here; Unite To Get the Benefits
The real world is sometimes quite a sober affair, isn’t it… As Ed said, “pour yourself a beverage of your choice, and mull over this one”! (https://twitter.com/griffen_ed/status/1266017635881361409)
Which ligand-protein activities cause adverse events? Interview with the author http://www.drugdiscovery.net/2020/06/15/which-ligand-protein-activities-cause-adverse-events-interview-with-the-author/
So does my drug cause side effects if it hits an ‘off-target’? Or is safety profiling simply a ‘worrying machine’? Well… it depends, and adverse event data is tricky
… and beyond:
A new treasure from my current explorations of Internet radio stations…
“Radio Improvisando”, proper Rock for the current sunny afternoons (from Columbia, but mostly music):
And this is really beautiful:
Cesaria Evora – Live d’amor (Paris 2004)
So that’s it from my side, for now. If you wish to present at one of our next Cheminformatics Meetings, whether virtually or in person, please let me know, and likewise if you have any information for me to circulate to this audience, cheers!
All the best,